Spero Therapeutics Inc (SPRO.O)

+ 收藏

资产负债表(Spero Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231
原始币种 美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见63,527,000.0082,271,000.00
 应收关联方款项(元) 会员可见会员可见会员可见会员可见50,761,000.0049,198,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见7,930,000.008,685,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见122,218,000.00140,154,000.00
非流动资产:
 物业、厂房及设备(元) -----2,000.00
 预付款项及其他长期应收款非流动(元) ----23,585,000.0023,211,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见4,078,000.004,336,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见27,663,000.0027,549,000.00
总资产(元) 会员可见会员可见会员可见会员可见149,881,000.00167,703,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见1,732,000.001,725,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见2,696,000.003,066,000.00
 应付税项流动(元) 会员可见会员可见会员可见会员可见387,000.00387,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见10,011,000.005,380,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见30,807,000.0031,263,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见45,633,000.0041,821,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见3,206,000.003,519,000.00
 递延收入非流动(元) 会员可见会员可见会员可见会员可见20,517,000.0026,076,000.00
 非流动负债其他项目(元) ---会员可见25,000.0038,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见23,748,000.0029,633,000.00
总负债(元) 会员可见会员可见会员可见会员可见69,381,000.0071,454,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见54,000.0054,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见502,049,000.00499,936,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-421,603,000.00-403,741,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见80,500,000.0096,249,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见80,500,000.0096,249,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见149,881,000.00167,703,000.00
公告日期 2025-08-122025-05-132025-03-272024-11-142024-08-052024-05-15
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院